Sign Out
Posology: Primary vaccination: Individuals 12 months of age and older: One single dose (0.5 mL).
Booster vaccination: A single 0.5 mL dose of MenQuadfi may be used to boost subjects who have previously received a meningococcal vaccine containing the same serogroups (see Pharmacology: Pharmacodynamics under Actions).
There are no data available to indicate the need for or timing of a booster dose of MenQuadfi (see Pharmacology: Pharmacodynamics under Actions).
Other paediatric population: The safety and immunogenicity of MenQuadfi in individuals under 12 months of age have not yet been established.
Method of administration: For intramuscular injection only, preferably in the deltoid region or anterolateral thigh depending on the recipient's age and muscle mass.
For instructions on handling of the vaccine before administration, see Special precautions for disposal and other handling under Cautions for Usage.
